Last reviewed · How we verify

NCT04744337

TMJ Adaptations by Orthodontic Treatment in Adolescent Females With Angle's Class II Division 2 Malocclusion: MRI Study

Completed NA Last updated 8 February 2021
What this trial tests

NA trial testing orthodontic treatment in Class II Division 2 Malocclusion in 14 participants. Completed in 1 April 2019.

Timeline
1 December 2017
Primary endpoint
1 January 2019
1 April 2019

Quick facts

Lead sponsorPostgraduate Institute of Dental Sciences Rohtak
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment14
Start date1 December 2017
Primary completion1 January 2019
Estimated completion1 April 2019
Sites1 location across India

Drugs / interventions tested

Conditions studied

Sponsor

Postgraduate Institute of Dental Sciences Rohtak

Who can join

Adults 13 to 15, female only, with Class II Division 2 Malocclusion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to document the changes brought about in the internal anatomic relationships of the TMJ complex,positional changes of glenoid fossa with respect to adjacent cranial structures after completion of fixed orthodontic treatment in adolescent females initially treated with removable functional appliances for skeletal class II, Angle's class II division 2 Malocclusion.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of orthodontic treatment

Trials testing the same drug.

Other recruiting trials for Class II Division 2 Malocclusion

Currently open trials in the same condition.

Other Postgraduate Institute of Dental Sciences Rohtak trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04744337.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing